Vertex Pharmaceuticals
VRTX
#153
Rank
NZ$194.32 B
Marketcap
$754.58
Share price
1.21%
Change (1 day)
5.92%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): NZ$0.38 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.62 Billion. In 2023 the company made an earning of NZ$7.91 Billion, an increase over its 2022 earnings that were of NZ$7.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.38 B-95.18%
2023 NZ$7.91 B3.19%
2022 NZ$7.66 B53.56%
2021 NZ$4.99 B-12.06%
2020 NZ$5.67 B118.45%
2019 NZ$2.59 B120.64%
2018 NZ$1.17 B1473.64%
2017 NZ$74.85 M197.6%
2016 NZ$25.15 M-102.97%
2015 -NZ$0.85 Billion-28.46%
2014 -NZ$1.19 Billion-51.5%
2013 -NZ$2.45 Billion-30584.68%
2012 NZ$8 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.06 Billion
2007 -NZ$0.74 Billion83.1%
2006 -NZ$0.41 Billion59.02%
2005 -NZ$0.26 Billion3.28%
2004 -NZ$0.25 Billion-38.16%
2003 -NZ$0.4 Billion
2000 -NZ$68.03 Million-20.38%
1999 -NZ$85.44 Million31.62%
1998 -NZ$64.91 Million91.05%
1997 -NZ$33.98 Million-36.24%
1996 -NZ$53.29 Million12.45%
1995 -NZ$47.39 Million27.4%
1994 -NZ$37.2 Million-1833.33%
1993 NZ$2.14 M-112.12%
1992 -NZ$17.71 Million175%
1991 -NZ$6.44 Million-12.2%
1990 -NZ$7.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.31 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.86 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.77 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.31 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.89 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.2 Billion-135.86%๐Ÿ‡บ๐Ÿ‡ธ USA